主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VTGN
#3997
Vistagen Therapeutics, Inc. Common Stock
0.607
3
USD
-3.73%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-3.73%
每月变动
+17.90%
6个月变化
+17.90%
年变化
+17.90%
前一天收盘价
0.630
8
Open
0.607
3
Bid
0.607
3
Ask
0.610
3
Low
0.607
3
High
0.607
3
交易量
6
市场
股票
医疗保健
VTGN
Open full chart
Financials
Overview
声明
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
28.86 M
29.16 M
30.68 M
39.5 M
39.62 M
—
Valuation ratios
Enterprise value
10.43 M
5.76 M
12.38 M
77.42 M
-21.15 M
74.42 M
Price to earnings ratio
-3.17
-1.5
-1.12
-1.86
-0.35
-4.82
Price to sales ratio
119.04
158.83
93.91
161.47
29.23
443.43
Price to cash flow ratio
-2.1
-1.83
-1.25
-2.17
-0.39
-5.63
Price to book ratio
0.2
1.1
0.21
0.41
0.09
1.81
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.15
0.16
0.22
0.24
0.29
0.91
Return on equity %
0.17
0.19
0.27
0.29
0.37
1.12
Return on invested capital %
1 097.64
1 064.54
1 079.78
1 372.79
1 533.47
5 050.58
Gross margin %
100
100
100
100
100
400
Operating margin %
7 560
76.29 K
6 477.05
7 772.48
6 450.83
96.99 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
7 044.5
71.76 K
6 186.48
7 525.97
6 237.29
91.71 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
9.35
6.51
5.98
5.79
4.67
22.95
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.01
0.01
0.01
—
Long term debt to total equity ratio
—
—
0.02
0.01
0.01
—
Per share metrics
Operating cash flow per share
0.33
0.33
0.59
0.39
0.42
1.72
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.88
2.61
1.98
2.16
1.46
8.21
Net current asset value per share
2.93
2.66
2.09
2.21
1.5
8.45
Tangible book value per share
2.64
2.28
1.78
1.86
1.21
7.12
Working capital per share
2.62
2.25
1.74
1.83
1.18
6.99
Book value per share
2.64
2.28
1.78
1.86
1.21
7.12
新闻
Vistagen Therapeutics裁员20%以控制成本
Vistagen Therapeutics reduces workforce by 20 percent to manage costs
VistaGen在TD Cowen大会上展示:聚焦信息素平台技术
VistaGen at TD Cowen Conference: Pherine Platform in Focus
Vistagen Therapeutics, Inc. (VTGN) Q3 2026 Earnings Call Transcript
VistaGen Therapeutics 2026年第三季度财报电话会议:AI驱动的试验分析亮点
Earnings call transcript: VistaGen Therapeutics Q3 2026 highlights AI-driven trial analysis
VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Lags Revenue Estimates
Vistagen Therapeutics公司的fasedienol三期临床试验未达终点
Vistagen Therapeutics reports Phase 3 trial for fasedienol did not meet endpoint
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47%
美国股市收低;截至收盘道琼斯工业平均指数下跌0.47%